M.I.TECH Co.Ltd (179290) - Cash Flow Conversion Efficiency
Based on the latest financial reports, M.I.TECH Co.Ltd (179290) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.62 Billion ≈ $3.81 Million USD) by net assets (₩120.80 Billion ≈ $81.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
M.I.TECH Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how M.I.TECH Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 179290 current and long-term liabilities for a breakdown of total debt and financial obligations.
M.I.TECH Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of M.I.TECH Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Currenc Group Inc. Ordinary Shares
NASDAQ:CURR
|
-0.355x |
|
S.Kijchai Enterprise Public Company Limited
BK:SKN
|
0.023x |
|
IG Petrochemicals Limited
NSE:IGPL
|
-0.030x |
|
K N Kenanga Holdings Bhd
KLSE:6483
|
0.110x |
|
Lastminute.com NV
F:09B
|
-0.327x |
|
The Andhra Sugars Limited
NSE:ANDHRSUGAR
|
0.065x |
|
ANDHRA PAPER LIMITED
NSE:ANDHRAPAP
|
0.033x |
|
Telechips Inc
KQ:054450
|
0.019x |
Annual Cash Flow Conversion Efficiency for M.I.TECH Co.Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of M.I.TECH Co.Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of M.I.TECH Co.Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩108.83 Billion ≈ $73.75 Million |
₩23.66 Billion ≈ $16.04 Million |
0.217x | +13.48% |
| 2023-12-31 | ₩92.94 Billion ≈ $62.98 Million |
₩17.81 Billion ≈ $12.07 Million |
0.192x | +86.33% |
| 2022-12-31 | ₩83.55 Billion ≈ $56.62 Million |
₩8.59 Billion ≈ $5.82 Million |
0.103x | -59.70% |
| 2021-12-31 | ₩64.76 Billion ≈ $43.89 Million |
₩16.52 Billion ≈ $11.20 Million |
0.255x | +262.09% |
| 2020-12-31 | ₩55.40 Billion ≈ $37.55 Million |
₩3.90 Billion ≈ $2.65 Million |
0.070x | +9.45% |
| 2019-12-31 | ₩48.25 Billion ≈ $32.70 Million |
₩3.11 Billion ≈ $2.11 Million |
0.064x | +41.35% |
| 2018-12-31 | ₩44.77 Billion ≈ $30.34 Million |
₩2.04 Billion ≈ $1.38 Million |
0.046x | -11.71% |
| 2017-12-31 | ₩18.67 Billion ≈ $12.66 Million |
₩963.43 Million ≈ $652.90K |
0.052x | -69.14% |
| 2016-12-31 | ₩16.63 Billion ≈ $11.27 Million |
₩2.78 Billion ≈ $1.88 Million |
0.167x | +462.76% |
| 2015-12-31 | ₩14.71 Billion ≈ $9.97 Million |
₩-677.68 Million ≈ $-459.25K |
-0.046x | -- |
About M.I.TECH Co.Ltd
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more